Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209806 · ClinicalTrials.gov registry record · NA
The Effects of Moviprep With Simethicone on Colonic Bubbles
A NA study of Bubbles in Colon at Time of Colonoscopy, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT01209806: Completed NA study of Bubbles in Colon at Time of Colonoscopy, sponsored by Thomas Jefferson University.
NCT01209806 is a NA study of Bubbles in Colon at Time of Colonoscopy that has completed, run by Thomas Jefferson University. The registered enrollment target is 140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01209806, a NA study of Bubbles in Colon at Time of Colonoscopy, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the administration of PEG along with simethicone will reduce the incidence of colonic bubbles that interfere with polyp detection.
Primary Outcome
Successful cleansing defined as score or excellent or good Unsuccessful cleansing defined as score of fair or inadequate
Conditions Studied
Interventions
- DRUG simethicone
Study Locations (1)
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01209806 record still lists
NCT01209806 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Bubbles in Colon at Time of Colonoscopy appearing as the primary indexed condition, and to 1 intervention - of which simethicone is the first listed.
NCT01209806 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01209806 about?
NCT01209806 is a clinical study titled "The Effects of Moviprep With Simethicone on Colonic Bubbles". The purpose of this study is to determine whether the administration of PEG along with simethicone will reduce the incidence of colonic bubbles that interfere with polyp detection.
What is the current status of trial NCT01209806?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2009-11. Estimated completion is 2012-09.
What conditions does trial NCT01209806 study?
This clinical trial studies the following conditions: Bubbles in Colon at Time of Colonoscopy.
What interventions are being tested in trial NCT01209806?
The interventions under investigation include: simethicone (DRUG).
Who is sponsoring clinical trial NCT01209806?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01209806 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01209806's enrollment target sits among peer trials
140 713th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia